The best biotech plays outside the GLP-1 weight-loss market

By Yahoo! Finance | Sep 19, 2024 at 05:27 PM EST

BMO Capital Markets' Evan Seigerman discusses the booming biotech sector, highlighting GLP-1 weight-loss drugs' demand. He also points out opportunities in companies like Regeneron and Vertex, emphasizing Vertex's leadership in cystic fibrosis research and upcoming approvals for new treatments.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.